Clinical Trial Update: HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing HCT+F to HCT alone in critically ill septic shock patients has completed recruitment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• HCT
• HCT+F

Snippet

Sponsor: University of Tennessee Medical Center | Conditions: Septic Shock | Phase 2 | Status: COMPLETED | Results posted: 2021-05-20